Prepared by CTEP 4/1/2016 Page 1 of 8 CURRENT Investigator Brochure List Date Posted Size

Prepared by CTEP 4/1/2016 Page 1 of 8 CURRENT Investigator Brochure List Date Posted Size

CURRENT Investigator Brochure List Date Posted Size 003801 - Methoxyamine hydrochloride (TRC102) - 10-14 - Ver3..pdf 10/09/2014 1,021 KB 048006 - 5-Fluoro-2’-deoxycytidine (FdCyd) - 01-14.pdf 01/09/2014 537 KB 102816 - Azacitidine - 08-15 Ver 12.pdf 10/01/2015 3 MB 102816 - Azacitidine - Summary of Changes - 08-15 Ver 12.pdf 10/01/2015 140 KB 127716 - Decitabine (5-aza-2'-deoxycytidine) - 04-12 - Ver6.pdf 09/24/2012 1 MB 281612 - DMS612 (Dimethane Sulfonate) - 04-14.pdf 04/24/2014 175 KB 301463 - Poly ICLC Hiltonol - 05-14 - Ver9.pdf 08/26/2014 412 KB 630176 - Romidepsin (Depsipeptide; FK228) - 04-15 - Ver 14.pdf 04/16/2015 939 KB 630176 - Romidepsin (Depsipeptide; FK228) - Summary of Changes - 04-15 - Ver 14.pdf 04/16/2015 93 KB 639966 - Perifosine - 03-14 - Ver 14.pdf 04/14/2014 4 MB 663249 - Triapine (injection and capsule) - 09-15.pdf 10/08/2015 1 MB 663249 - Triapine (injection and capsule) - Summary of Changes - 09-15.pdf 10/08/2015 125 KB 66847 - Thalidomide (Thalomid) - 12-15 - Ver14.pdf 03/17/2016 1 MB 66847 - Thalidomide (Thalomid) Summary of changes - 12-15 - Ver14.pdf 03/17/2016 165 KB 672423 - InterLEUKIN-12 - 12-14.pdf 02/09/2015 1 MB 676422 - Immunotoxin LMB-2 (Anti-Tac(Fv)-PE-38) - 05-15.pdf 06/02/2015 466 KB 681239 - Bortezomib - 06-15 - Ver18.pdf 08/11/2015 1 MB 681239 - Bortezomib - Summary Of Changes - 06-15 - Ver18.pdf 08/11/2015 153 KB Prepared by CTEP 4/1/2016 Page 1 of 8 CURRENT Investigator Brochure List Date Posted Size 683864 - Temsirolimus (PF-05208748) - 12-15.pdf 01/28/2016 909 KB 683864 - Temsirolimus (PF-05208748) - Summary of Changes - 12-15.pdf 01/28/2016 3 MB 686673 - Nelarabine (506U78) - 11-05 - Ver7.pdf 11/19/2014 1 MB 688097 - RO0452317 Herceptin (Trastuzumab) - 10-15 - Ver16.pdf 11/02/2015 2 MB 696599 - FLT3 Ligand CDX-301 - 11-15 Ver 3.pdf 11/30/2015 992 KB 701852 - Vorinostat (SAHA, Zolinza) - 08 -13 - Ver 8.pdf 08/05/2013 8 MB 702818 - R115777 (tipifarnib, Zarnestra) - 05-08 - Ver11.pdf 05/14/2009 2 MB 702818 - R115777 (tipifarnib, Zarnestra) - Summary of Changes - 05-08 - Ver11.pdf 05/14/2009 35 KB 703813-Revlimid (Lenalidomide)- 02-15 -Ver 18.pdf 03/30/2015 1 MB 703813-Revlimid (Lenalidomide)- Summary of Changes - 02-15- Ver 18.pdf 03/30/2015 173 KB 704865 - Bevacizumab(Avastin) - 11-15 - Ver.23.pdf 12/09/2015 1 MB 706995 - MS-275 (SNDX-275, Entinostat) - 11-15 Ver14.0.pdf 12/17/2015 1 MB 706995 - MS-275 (SNDX-275, Entinostat) - Summary of Changes - 11-15 Ver14.0.pdf 12/17/2015 53 KB 707389 -E7389(ERIBULIN)- Summary of Changes 08-14-Ver 12.pdf 01/26/2015 114 KB 707389 -E7389(ERIBULIN)-07-14-Ver 12.pdf 01/26/2015 1 MB 707389 -E7389(ERIBULIN)-Addendum -08-14-Ver 12.pdf 01/26/2015 80 KB 710428 - BMS 247550 (ixabepilone, Ixempra) - 06-09 - ver10.pdf 06/30/2009 1,010 KB 710658; 708039 - rF-TRICOM; rV-TRICOM - 08-10.pdf 10/05/2010 200 KB Prepared by CTEP 4/1/2016 Page 2 of 8 CURRENT Investigator Brochure List Date Posted Size 717170; 717171 - PROSTVAC-VF - 12-14 - Ver3.pdf 06/16/2015 1 MB 718781 - OSI-774 - Erlotinib (Tarceva) ASP5901 - 02-15 - Ver19.pdf 08/20/2015 1 MB 718781 - Summary Of Changes OSI-774 - Erlotinib (Tarceva) ASP5901 - 02-15 - Ver19.pdf 09/11/2015 94 KB 724770 - Ziv-aflibercept, VEGF-Trap, AVE0005 -12-15-Ver 14.pdf 02/17/2016 2 MB 724770 - Ziv-aflibercept, VEGF-Trap, AVE0005- Summary Of Changes -12-15-Ver 14.pdf 02/17/2016 171 KB 724772 - BAY 43-9006 (SORAFENIB) - 08-15-Ver16.0.pdf 01/28/2016 1 MB 726188 -5-iodo-2-pyrimidinone - deoxyribose-IPdR - 01-15.pdf 01/26/2015 457 KB 726388 - CAT-5001 (SS1(dsFv) PE38) - 7-13.pdf 07/16/2013 491 KB 726630 - PXD-101(Belinostat) - 04-15 - Ver 12.pdf 07/29/2015 2 MB 727027; 727026 - PANVAC-VF - 12-13.pdf 12/27/2013 259 KB 727989 - GW572016 (Lapatinib) - 01-16 - Ver 17.pdf 03/31/2016 1 MB 727989 - GW572016 (Lapatinib) - Summary of Changes - 01-16 - Ver 17.pdf 03/31/2016 53 KB 729968 -Reolysin - 02-16 - Ver15..pdf 03/31/2016 1 MB 732208 - AZD2171 (Cediranib, Recentin) Appendix A - 09-15 - Ver17.pdf 09/24/2015 174 KB 732208 - AZD2171 (Cediranib, Recentin)-09-15 - Ver17.pdf 09/24/2015 892 KB 732442 -Ipilimumab-(MDX-010; Transfectoma-derived) - 03-16 - Ver 19.pdf 03/31/2016 11 MB 732517 - BMS-354825 (DASATINIB) - 06-15 - Ver 15.pdf 08/07/2015 10 MB 732517 - BMS-354825 (DASATINIB) Summary of Changes - 06- 15 - Ver 15.pdf 08/07/2015 1 MB Prepared by CTEP 4/1/2016 Page 3 of 8 CURRENT Investigator Brochure List Date Posted Size 733504 - Everolimus (Afinitor RAD001) - 05-15 - Ver 14.pdf 11/02/2015 822 KB 733504 - Everolimus (Afinitor RAD001) Erratum - 05-15 - Ver 14.pdf 11/02/2015 753 KB 733504 - Everolimus (Afinitor RAD001) Summary of Changes - 05-15 - Ver 14.pdf 11/02/2015 143 KB 736511 - Sunitinib Malate - Investigator's Brochure - 06-15.pdf 01/07/2016 2 MB 736511 - Sunitinib Malate - Summary Of Changes - 06-15.pdf 01/07/2016 3 MB 737664 - Veliparib (ABT-888) - 06-15 - Ver9.pdf 12/17/2015 6 MB 737754 - GW786034-(Pazopanib) - 12-14 - Ver12.PDF 02/20/2015 2 MB 737754 - GW786034-(Pazopanib) -Memo- 12-14 - Ver12 - Redistribution memo.pdf 02/20/2015 158 KB 737754 - GW786034-(Pazopanib) -Memo- 12-14 - Ver12.pdf 02/20/2015 189 KB 740102 - Pertuzumab - 02-15- ver14.pdf 03/18/2015 1 MB 742460 - IMC-A12 (Cixutumumab) - 09-13-.pdf 11/20/2013 4 MB 745101 - Recombinant Human IL-15 - 06-15.pdf 07/01/2015 3 MB 747135 - SCH 727965 (Dinaciclib, MK-7965) - 10-14 - Ver.11.pdf 10/07/2014 6 MB 747691-Vismodegib (GDC- 0449) -01-16-Ver 10.pdf 02/05/2016 2 MB 747856 - Olaparib(AZD2281) -06-15-Ver12.pdf 10/08/2015 2 MB 747888 - MLN8237 - 07-15 - Ver10.pdf 11/02/2015 2 MB 748645 -PCI-32765 (Ibrutinib) - 06-15 - Ver9.pdf 07/13/2015 710 KB 748645 -PCI-32765 (Ibrutinib) - Summary Of Changes - 06-15 - Ver9.PDF 07/13/2015 102 KB Prepared by CTEP 4/1/2016 Page 4 of 8 CURRENT Investigator Brochure List Date Posted Size 748645 -PCI-32765 (Ibrutinib) - Addendum 1 06-15 - Ver9.pdf 01/07/2016 64 KB 748645 -PCI-32765 (Ibrutinib) - Addendum 2 06-15 - Ver9.pdf 01/07/2016 79 KB 748726 - BMS936558 (Nivolumab) - 06-15 - Ver14.pdf 07/14/2015 4 MB 748726 - BMS936558 (Nivolumab) Erratum 01 - 06-15 - Ver14.pdf 01/21/2016 2 MB 748727; 741078 - AZD6244 (Capsules and Powder&Oral Suspension) - 01-16 - Ver 16.pdf 01/28/2016 6 MB 749005 - Crizotinib (PF-02341066) - 10-15.pdf 01/07/2016 927 KB 749005 - Crizotinib (PF-02341066) -Summary of Changes - 10- 15.pdf 01/07/2016 1 MB 749225 - RO4929097 - 06-10 - ver4.pdf 07/13/2010 2 MB 749607-MK-2206-02-14-Ver7.pdf 09/22/2014 2 MB 749710 - SGN-35 - 10-15 - Ver 13.pdf 11/02/2015 1 MB 749712 - AT13387 - 03-15 - Ver 10.pdf 03/30/2015 3 MB 750008 - AMG 479 (Ganitumab) - 11-13 - Ver 9.pdf 05/23/2014 665 KB 750008 - AMG 479 (Ganitumab)-Summary of Changes - 11-13 - Ver 9.pdf 05/23/2014 131 KB 750238 - ABT-263 - (Navitoclax) 12-15 - Ver 12.pdf 01/05/2016 2 MB 750393 - Z-Endoxifen HCL - 01-15.pdf 02/18/2015 668 KB 750691 - Afatinib - 07 -15 -Ver16.pdf 09/21/2015 2 MB 750832 - ARQ 197 - 11-13 - Ver9.0.pdf 11/25/2013 2 MB 750832 - ARQ 197 - SOC - 11-13 - Ver9.0.pdf 11/25/2013 170 KB Prepared by CTEP 4/1/2016 Page 5 of 8 CURRENT Investigator Brochure List Date Posted Size 751082 - Linsitinib (ASP7487, OSI-906) - 03-15 - Ver 5..pdf 05/14/2015 3 MB 751084 -AZD1775 - 02-15 - Ver12.pdf 03/19/2015 1 MB 751173 - Trebananib (AMG 386) - 12-15 Ver 11.pdf 01/20/2016 1 MB 751173 - Trebananib (AMG 386) Summary of Changes- 12-15 Ver 11.pdf 01/20/2016 71 KB 754227 - TRC105-01-16-Ver9.0.pdf 02/17/2016 2 MB 756502 - (birinapant)TL32711 , 04-15, Ver7.pdf 11/19/2015 2 MB 761968 - Cabozantinib(XL184) - 07-15 - Ver 11-Summary of Changes.pdf 07/28/2015 408 KB 761968 -Cabozantinib(XL184) - 07-15 - Vers 11.pdf 07/28/2015 1 MB 763093 - GSK1120212-Trametinib - 01-16 - Ver7.pdf 02/17/2016 1 MB 763093 - GSK1120212-Trametinib - Summary Of Changes - 01-16 - Ver7.pdf 02/17/2016 140 KB 763737 - Glembatumumab Vedotin-CDX-011 -08-15 -ver6.pdf 09/28/2015 3 MB 763760 - GSK2118436 (Dabrafenib) -10-15 -Ver7.pdf 11/09/2015 2 MB 763760 - GSK2118436 (Dabrafenib) Mono and in Combination with Trametinib Release Memo_IB V7_14....pdf 11/09/2015 326 KB 764038 – Chimeric Monoclonal Antibody - Summary of Changes14.18 – 09-15.PDF 10/22/2015 1 MB 764038 – Chimeric Monoclonal Antibody 14.18 – 09-15.PDF 10/22/2015 5 MB 765986 - Blinatumomab (AMG 103) - 04-15 - Ver 16.1.pdf 01/20/2016 1 MB 765986 - Blinatumomab (AMG 103) Summary of Changes - 04- 15 - Ver 16.1.pdf 01/20/2016 174 KB 766086 - INCB024360 - 12-15 - Ver7.pdf 01/28/2016 1 MB Prepared by CTEP 4/1/2016 Page 6 of 8 CURRENT Investigator Brochure List Date Posted Size 767034 - GSK2141795 - 09-14 - Ver7.PDF 10/15/2014 746 KB 767034 - GSK2141795 - SOC - 09-14 - Ver7.pdf 03/02/2015 769 KB 767909 - Pomalidomide (CC-4047) - 05-15 - Ver 21.pdf 07/02/2015 2 MB 767909 - Pomalidomide (CC-4047) - Summary of Changes - 05- 15 - Ver 21.pdf 07/02/2015 133 KB 768435 - MLN0128 - 03-15 - Ver 8.pdf 04/10/2015 834 KB 771561 - Talazoparib (BMN 673) - 04-15 - Ver6.pdf 05/14/2015 423 KB 772256 – Palbociclib (PD-0332991) 12-15.pdf 01/07/2016 1 MB 772256 – Palbociclib (PD-0332991) Summary of Changes - 12- 15.pdf 01/07/2016 3 MB 772468 - CDX-1401 - 10-13 - Ver3.pdf 11/12/2013 2 MB 776864 - MK-3475 - 08-15 - Ver10.pdf 09/11/2015 2 MB 777169 - Ganetespib - 11-15 - Ver 11.pdf 12/01/2015 2 MB 778372 - (Varlilumab) CDX-1127 - 07-14 - Ver 4.0.pdf 01/20/2016 2 MB 778709 - MEDI4736 - 09-15 - Ver 8.pdf 10/01/2015 3 MB 778795 - GDC-0032 (RO5537381 Taselisib) - 12-15 - Ver 6.pdf 12/18/2015 759 KB 780162 - VX-970 - 05-15 - Ver5.0.pdf 08/28/2015 2 MB 780263 - Ado-Trastuzumab Emtansine - 12-14 - Ver.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    8 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us